Vor Biopharma Inc. (VOR) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 10 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for VOR is $50.50, representing a +223.7% upside from the current price of $15.6. Price targets range from a low of $46.00 to a high of $55.00.
